Nuclear Medicine & Radiation Therapy

ISSN: 2155-9619

Open Access

Radionuclide Therapy in Solid Tumors

Radionuclide Therapy in Solid Tumours is done by introducing radial dose of beta-particle-emitting and alpha-particle-emitting molecules localized either solely within endothelial cells of tumour vasculature or diffusing from the vasculature throughout the adjacent viable tumour cells.

Peptide receptor radionuclide therapy (PRRT) or hormone-delivered radiotherapy, which is otherwise known as Radionuclide therapy in solid tumors treatment has a major role. Radionuclide therapy in solid tumors recognition, a dose of radiation could prevent the tumor growth. Radionuclide therapy in solid tumors treatment radioactive substances are chemically combined with hormones. Radionuclide therapy in solid tumors, this substance known as NET is injected into patient.

High Impact List of Articles
Conference Proceedings
arrow_upward arrow_upward